Beyond virtual and physical access, CarePortMD lowers the barriers to access of screening and diagnostic services that are grossly under-utilized. For example, we are the first company in the United States to offer a retail-based autonomous diagnostic screen for diabetic retinopathy- a condition that will affect 85% of diabetics over 20 years and is the leading cause of adult blindness. Annual screening is recommended by the American Diabetes Association, yet only a third of eligible patients get tested. During the COVID-19 pandemic, access to eye doctors has been restricted, driving screening rates further down, Diabetic retinopathy screening is in fact a HEDIS (Healthcare Effectiveness Data and Information Set) measure used to benchmark the quality of health plans. CarePortMD now offers this service at over 20 locations across the State of Delaware, making it possible for patients with diabetes to be screened in 5 minutes, with real-time results, and referral to an eye specialist within 24 hours when positive. Similarly, CarePortMD network lowers barriers to services like immunizations and lab testing, which are of particular importance to diabetics with compromised immune systems and co-morbidities.
CarePortMD Retinopathy Screening in the National News
Please email firstname.lastname@example.org to schedule Diabetic Retinopathy Screening at your facility!